Follow
CAR-T cell therapy
Chimeric antigen receptor (CAR) T cell therapy is a form of T cell engineering where T cells are obtained from a patient and engineered in a laboratory to better kill the patient's cancer cells. Specifically, CAR T cells are modified to express a receptor on their surface that recognizes the specific antigen present on the patient's cancer cells.
APR 20, 2022 | 7:30 AM
The COVID-19 pandemic has taken a dramatic toll worldwide. Its impact possibly has been the most palpable amongst uniquely vulnerable groups of patients, such as patients with a cancer diagn...
MAR 24, 2022 | 8:00 AM
Date: March 24, 2021 Time: 08:00am (PDT), 11:00pm (EDT) Simply enough, we want to treat our cells well. Afterall, we want them to tell us their stories in basic research or work for us in th...
DEC 09, 2021 | 8:00 AM
Date: December 9, 2021 Time: 8:00am (PDT), 11:00am (EDT) Engineering human regulatory T cells (Tregs) with a chimeric antigen receptor (CAR) targeting donorderived human leukocyte antigen (H...
DEC 08, 2021 | 8:00 AM
Date: December 08, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn how enrichment of primary dendritic cell (DC) subsets and sustainable DC manufacturing advances DC-based cell therapies. In th...
DEC 02, 2021 | 8:00 AM
Date: December 2, 2021 Time: 8:00am (PDT), 11:00am (EDT) Effective immunotherapy of pancreatic ductal adenocarcinoma (PDAC) is hampered by the lack of suitable tumor-specific antigens. To ad...
NOV 30, 2021 | 8:00 AM
Date: November 30, 2021 Time: 8:00am (PDT), 11:00am (EDT) The DNA Vector Lab at the German Cancer Research Center (DKFZ) has developed Nano-S/MARt (nS/MARt), a novel DNA Vector platform that...
NOV 18, 2021 | 8:00 AM
Date: November 18, 2021 Time: 8:00am (PDT), 11:00am (EDT) Keep ahead in CAR T and CAR NK cell research. We introduce advanced techniques for generating and characterizing engineered immune c...
NOV 16, 2021 | 8:00 AM
Date: November 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) The unique suppressive function of regulatory T cells (Treg cells) makes them an interesting target cell population to study. In rec...
NOV 03, 2021 | 7:00 AM
Date: November 3, 2021 Time: 7:00am (PDT), 10:00am (EDT) The reconstitution of a fully functional human immune system in mouse after engraftment of purified hCD34+ hematopoietic cells provid...
NOV 02, 2021 | 9:00 AM
Date: November 2, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Flow cytometry is a powerful technique for the analysis of multiple parameters of individual cells within heterogeneous populations....
OCT 28, 2021 | 8:00 AM
Date: October 28, 2021 Time: 8:00am (PDT), 11:00am (EDT) Today’s health industry is leveraging new, cutting-edge Cell & Gene Therapies (CGTs) to address a variety of medical illnes...
OCT 12, 2021 | 8:00 AM
Date: October 12, 2021 Time: 8:00am (PDT), 11:00am (EDT) CRISPR-Cas9 is a nuclease-based genome editing system which has seen exponential growth in adoption with broad applications from basi...
OCT 07, 2021 | 11:55 PM
Summary: Cancer neoantigens are highly specific to the tumor, potently immunogenic and can be targeted by both vaccines and engineered cellular therapies. This talk will introduce the defini...
OCT 06, 2021 | 12:00 PM
Advancements in immuno-oncology have been moving at an ever-quickening pace. From the development of new CAR-T therapies to a better understanding of the mechanism of action of monoclonal an...
OCT 06, 2021 | 10:30 AM
Effective immunotherapy of pancreatic ductal adenocarcinoma (PDAC) is hampered by the lack of suitable tumor-specific antigens. To address this challenge, we have combined high-throughput fl...
OCT 05, 2021 | 7:00 AM
Date: October 05, 2021 Time: 7:00am (PDT), 10:00am (EDT) After new users become familiar with flow cytometry instrumentation and learn how to set up the instrument and acquire data, the next...
SEP 28, 2021 | 8:00 AM
Date: September 28, 2021 Time: 8:00am (PDT), 11:00am (EDT) Flow cytometry provides many advantages including single-cell quantitative analysis, high sample throughput, and multiplex cell cha...
SEP 09, 2021 | 8:00 AM
Date: September 09, 2021 Time: 8:00am (PDT), 11:00am (EDT) Human pluripotent stem cells (PSCs) hold great potentials in regenerative therapies. In this webinar, Chao will first present the c...
AUG 31, 2021 | 9:00 AM
Date: July 07, 2021 Time: 8:00am (PDT), 11:00am (EDT) The DNA damage response is extremely crucial in maintaining genomic integrity. Failure to repair damaged DNA can result in the propagati...
JUL 22, 2021 | 5:00 PM
Though tumor targeting using chimeric receptors (CAR) engineered to bind tumor-associated surface proteins such as CD19 in B cells have demonstrated remarkable efficacy in cancer, this thera...
OCT 06, 2021 | 12:00 PM
Advancements in immuno-oncology have been moving at an ever-quickening pace. From the development of new CAR-T therapies to a better understanding of the mechanism of action of monoclonal an...